COSCIENS Biopharma Inc T.AEZ

Primary Symbol: T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc > Re - The Stuff of Legends

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Jul 26, 2024 2:55pm

94 Views

Post# 36150368

RE:Re - The Stuff of Legends

"The only legend gagnon has right now is how he can take a stock and watch it devalue from a high of $13.00 to $7.65 in a few short months."

LOL!

There has been no news released yet as they complete the merger, approve the new Board of Directors, and file to have the name changed and stock symbol as well as prepare the new branding and website. The event chain of transformational news awaits!

Ronald W. Miller, Chair of the Company:

“With the successful completion of this merger, we are now optimized to bring value-driving, transformational products to the market.”

The stock was as low as $5.40 when you were bashing and it shot up to $10. That's an 85% move and you were bashing the stock!